IPLEX and the Telephone Game: The difficulty in separating myth from reality on the internet

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 3, 2009, Pages 182-184

  Bedlack, Richard S ^a   Silani, Vincenzo ^b   Cudkowicz, Merit Ester ^c  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MECASERMIN RINFABATE; HYBRID PROTEIN; RECOMBINANT SOMATOMEDIN C; SIGNAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACCESS TO INFORMATION; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; DRUG APPROVAL; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; DRUG USE; HUMAN; INTERNET; LEGAL ASPECT; MEDICAL INFORMATION; NOTE; ONLINE SYSTEM; PRESCRIPTION; PRIORITY JOURNAL; ARTICLE; CHILD; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PUBLIC OPINION; TELEPHONE; TREATMENT OUTCOME;

AMYOTROPHIC LATERAL SCLEROSIS; CHILD; CLINICAL TRIALS AS TOPIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERNET; PUBLIC OPINION; RECOMBINANT FUSION PROTEINS; TELEPHONE; TREATMENT OUTCOME;

EID: 67651176073     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802673059     Document Type: Note

References (21)

1. Williams RM, McDonald A, O'Savage M, Dunger DB. Mecasermin rinfabate: rhIGF-1/rhIGFBP-3 complex: IPLEX. Expert Opin Drug Metab Toxicol. 2008;4:311-24.
2. Insmed.com [home page on the internet]. Richmond: Insmed Incorporated; 2008 [cited 2008 November 25]. Available from: http://www.insmed.com/ iplex.php.
3. Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, et al. Effect of recombinant human insulin-like growth factor-1 on progression of ALS. A placebo-controlled study. The North American ALS/IGF-1 Study Group. Neurology. 1997:49:1621-30.
4. Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, et al. A placebo-controlled trial of insulin-like growth factor-1 in amyotrophic lateral sclerosis. European ALS/IGF-1 Study Group. Neurology. 1998;51:583-6.
5. Sorenson EJ, Windbank AJ, Madrekar JN, Bamlet WR, Appel SH, Armon C, et al. Subcutaneous IGF-1 is not beneficial in two-year ALS trial. Neurology. 2008;71:1770-5.
6. Indestructiblefilm.com [home page on the internet]. Winston Salem; The film Indescructible; 2007 [cited 2008 November 25]. Blog section [1 screen]. Available from http://indestructi blefilm.com/blog/?m-200711.
7. ALS.net. The website for the ALS Therapy Development Institute; 2005-2008 [cited 2008 November 25]. Blog section [1 screen]. Available from http://www.als.net/forum/ topic.asp?TOPIC_ID-1672&SearchTerms-iplex.
8. AIFA. Sclerosi Laterale Amiotrofica: Prospettive di trattamento e di ricerca. November 14, 2006.
9. AIFA. Insulin-Like growth Factor-1 (IGF-1) e Sclerosi Laterale Amiotrofica (SLA): Lo stato dell' arte. (with the experts Mario Melazzini (AISLA), Vincenzo Silani, Massimo Corbo, Nicola Vanacore, Francesco Nonino). November 21, 2006.
10. AISLA.it. [home page on the internet]. The website of the Italian ALS Association. IGF-1, ALS, and the State of the Art (in Italian). [cited 2007 November 23]. Available from http://www.assisla.it/documents/ IGF1_Stato_arte.htm
11. Subscript.bna.com [home page on the internet]. Available from http://subscript.bna.com/SAMPLES/lsl.nsf/22d0e1dc3 146c4e385256d03005ca272/378c88ae66e139608525729f0079b9f5?OpenDocument
12. MDA.com The website of the Muscular Dystrophy Association; 2006-2008 [cited 2008 December 5]. Research news section [1 screen]. Available from http://www.als-mda.org/research/news/081112iplex_als.html
13. ALS.net. [home page on the internet]. The website for the ALS Therapy Development Institute; 2008 [cited 2008 November 25]. Blog section [1 screen]. Available from http://www.als.net/forum/ topic.asp?TOPIC_ID=3614&SearchTerms-iplex.
14. Inspire.com [home page on the internet]. The website Inspire; 2005-2008 [cited 2008 November 25]. ALS discussion section [1 screen]. Available from http://www.inspire.com/groups/als-advocacy/discussion/iplex=1/.
15. Petitiononline.com [home page on the internet]. The website for online petitions; 1999-2007 [cited 2008 November 25]. IPLEX petition section [1 screen]. Available from http://www.petitiononline.com/iplex/ petition.html.
16. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, et al. Lithium delays progression of amyotrophic lateral sclerosis. PNAS. 2008;105:2052-7.
17. Youtube.com [home page on the internet]. The website You Tube; 2008 [cited 2008 November 26]. Available from; http://www.youtube.com/ watch?v=210IHwqkdp8.
18. Patientslikeme.com [home page on the internet]. The website Patients Like Me; 2005-2008 [cited 2008 November 25]. Treatments section [1 screen]. Available from http://www.patientslikeme.com/als/treatments/ show/777-lithium-carbonate.
19. Wohlsen M. Patient-led drug trials defy medical establishment [monograph on the internet]. Associated Press; 2008 [cited 2008 November 25]. Available from http://www.google.com/hostednews/ap/article/ ALeqM5hoh2DJB0ELSmjikYupXYq9eydSHQD94MPVSG0.
20. Bedlack RS, Pastula DM, Welsh E, Pulley D, Cudkowicz M. Scrutinizing enrollment in ALS clinical trials: Room for improvement? Amyotrophic Lateral Sclerosis. 2008;9: 257-65.
21. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E, Krebs L, et al. A quantitative survey of public attitudes toward cancer clinical trials [monograph on the internet]. New York; Harris Interactive, Inc; 2000 [cited 2008 November 25]. Available from http://cancertrialshelp.org/ CTHpdf/308-9.pdf